This report contains market size and forecasts of Ophthalmology Treatment in Global, including the following market information:
Global Ophthalmology Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Ophthalmology Treatment market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
Publisher has surveyed the Ophthalmology Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ophthalmology Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Ophthalmology Treatment Market Segment Percentages, By Type, 2020 (%)
Gels
Eye Solutions
Capsules & Tablets
Eye Drops
Ointments
China Ophthalmology Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Ophthalmology Treatment Market Segment Percentages, By Application, 2020 (%)
Hospital
Retail Pharmacy
Global Ophthalmology Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Ophthalmology Treatment Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Ophthalmology Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Ophthalmology Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Allergan
Aerie Pharmaceuticals
Pfizer
Valeant
Bayer
Genentech
Novartis
Regeneron
Takeda
Santen Pharmaceutical
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Ophthalmology Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ophthalmology Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ophthalmology Treatment Overall Market Size
2.1 Global Ophthalmology Treatment Market Size: 2021 VS 2027
2.2 Global Ophthalmology Treatment Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Ophthalmology Treatment Players in Global Market
3.2 Top Global Ophthalmology Treatment Companies Ranked by Revenue
3.3 Global Ophthalmology Treatment Revenue by Companies
3.4 Top 3 and Top 5 Ophthalmology Treatment Companies in Global Market, by Revenue in 2020
3.5 Global Companies Ophthalmology Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Ophthalmology Treatment Players in Global Market
3.6.1 List of Global Tier 1 Ophthalmology Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Ophthalmology Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Ophthalmology Treatment Market Size Markets, 2021 & 2027
4.1.2 Gels
4.1.3 Eye Solutions
4.1.4 Capsules & Tablets
4.1.5 Eye Drops
4.1.6 Ointments
4.2 By Type - Global Ophthalmology Treatment Revenue & Forecasts
4.2.1 By Type - Global Ophthalmology Treatment Revenue, 2016-2021
4.2.2 By Type - Global Ophthalmology Treatment Revenue, 2022-2027
4.2.3 By Type - Global Ophthalmology Treatment Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Ophthalmology Treatment Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.2 By Application - Global Ophthalmology Treatment Revenue & Forecasts
5.2.1 By Application - Global Ophthalmology Treatment Revenue, 2016-2021
5.2.2 By Application - Global Ophthalmology Treatment Revenue, 2022-2027
5.2.3 By Application - Global Ophthalmology Treatment Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Ophthalmology Treatment Market Size, 2021 & 2027
6.2 By Region - Global Ophthalmology Treatment Revenue & Forecasts
6.2.1 By Region - Global Ophthalmology Treatment Revenue, 2016-2021
6.2.2 By Region - Global Ophthalmology Treatment Revenue, 2022-2027
6.2.3 By Region - Global Ophthalmology Treatment Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Ophthalmology Treatment Revenue, 2016-2027
6.3.2 US Ophthalmology Treatment Market Size, 2016-2027
6.3.3 Canada Ophthalmology Treatment Market Size, 2016-2027
6.3.4 Mexico Ophthalmology Treatment Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Ophthalmology Treatment Revenue, 2016-2027
6.4.2 Germany Ophthalmology Treatment Market Size, 2016-2027
6.4.3 France Ophthalmology Treatment Market Size, 2016-2027
6.4.4 U.K. Ophthalmology Treatment Market Size, 2016-2027
6.4.5 Italy Ophthalmology Treatment Market Size, 2016-2027
6.4.6 Russia Ophthalmology Treatment Market Size, 2016-2027
6.4.7 Nordic Countries Ophthalmology Treatment Market Size, 2016-2027
6.4.8 Benelux Ophthalmology Treatment Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Ophthalmology Treatment Revenue, 2016-2027
6.5.2 China Ophthalmology Treatment Market Size, 2016-2027
6.5.3 Japan Ophthalmology Treatment Market Size, 2016-2027
6.5.4 South Korea Ophthalmology Treatment Market Size, 2016-2027
6.5.5 Southeast Asia Ophthalmology Treatment Market Size, 2016-2027
6.5.6 India Ophthalmology Treatment Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Ophthalmology Treatment Revenue, 2016-2027
6.6.2 Brazil Ophthalmology Treatment Market Size, 2016-2027
6.6.3 Argentina Ophthalmology Treatment Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Ophthalmology Treatment Revenue, 2016-2027
6.7.2 Turkey Ophthalmology Treatment Market Size, 2016-2027
6.7.3 Israel Ophthalmology Treatment Market Size, 2016-2027
6.7.4 Saudi Arabia Ophthalmology Treatment Market Size, 2016-2027
6.7.5 UAE Ophthalmology Treatment Market Size, 2016-2027
7 Players Profiles
7.1 Allergan
7.1.1 Allergan Corporate Summary
7.1.2 Allergan Business Overview
7.1.3 Allergan Ophthalmology Treatment Major Product Offerings
7.1.4 Allergan Ophthalmology Treatment Revenue in Global (2016-2021)
7.1.5 Allergan Key News
7.2 Aerie Pharmaceuticals
7.2.1 Aerie Pharmaceuticals Corporate Summary
7.2.2 Aerie Pharmaceuticals Business Overview
7.2.3 Aerie Pharmaceuticals Ophthalmology Treatment Major Product Offerings
7.2.4 Aerie Pharmaceuticals Ophthalmology Treatment Revenue in Global (2016-2021)
7.2.5 Aerie Pharmaceuticals Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Ophthalmology Treatment Major Product Offerings
7.3.4 Pfizer Ophthalmology Treatment Revenue in Global (2016-2021)
7.3.5 Pfizer Key News
7.4 Valeant
7.4.1 Valeant Corporate Summary
7.4.2 Valeant Business Overview
7.4.3 Valeant Ophthalmology Treatment Major Product Offerings
7.4.4 Valeant Ophthalmology Treatment Revenue in Global (2016-2021)
7.4.5 Valeant Key News
7.5 Bayer
7.5.1 Bayer Corporate Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Ophthalmology Treatment Major Product Offerings
7.5.4 Bayer Ophthalmology Treatment Revenue in Global (2016-2021)
7.5.5 Bayer Key News
7.6 Genentech
7.6.1 Genentech Corporate Summary
7.6.2 Genentech Business Overview
7.6.3 Genentech Ophthalmology Treatment Major Product Offerings
7.6.4 Genentech Ophthalmology Treatment Revenue in Global (2016-2021)
7.6.5 Genentech Key News
7.7 Novartis
7.7.1 Novartis Corporate Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Ophthalmology Treatment Major Product Offerings
7.4.4 Novartis Ophthalmology Treatment Revenue in Global (2016-2021)
7.7.5 Novartis Key News
7.8 Regeneron
7.8.1 Regeneron Corporate Summary
7.8.2 Regeneron Business Overview
7.8.3 Regeneron Ophthalmology Treatment Major Product Offerings
7.8.4 Regeneron Ophthalmology Treatment Revenue in Global (2016-2021)
7.8.5 Regeneron Key News
7.9 Takeda
7.9.1 Takeda Corporate Summary
7.9.2 Takeda Business Overview
7.9.3 Takeda Ophthalmology Treatment Major Product Offerings
7.9.4 Takeda Ophthalmology Treatment Revenue in Global (2016-2021)
7.9.5 Takeda Key News
7.10 Santen Pharmaceutical
7.10.1 Santen Pharmaceutical Corporate Summary
7.10.2 Santen Pharmaceutical Business Overview
7.10.3 Santen Pharmaceutical Ophthalmology Treatment Major Product Offerings
7.10.4 Santen Pharmaceutical Ophthalmology Treatment Revenue in Global (2016-2021)
7.10.5 Santen Pharmaceutical Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Ophthalmology Treatment Market Opportunities & Trends in Global Market
Table 2. Ophthalmology Treatment Market Drivers in Global Market
Table 3. Ophthalmology Treatment Market Restraints in Global Market
Table 4. Key Players of Ophthalmology Treatment in Global Market
Table 5. Top Ophthalmology Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Ophthalmology Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Ophthalmology Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Ophthalmology Treatment Product Type
Table 9. List of Global Tier 1 Ophthalmology Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ophthalmology Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Ophthalmology Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Ophthalmology Treatment Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Ophthalmology Treatment Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Ophthalmology Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Ophthalmology Treatment Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Ophthalmology Treatment Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Ophthalmology Treatment Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Ophthalmology Treatment Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Ophthalmology Treatment Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Ophthalmology Treatment Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Ophthalmology Treatment Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Ophthalmology Treatment Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Ophthalmology Treatment Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Ophthalmology Treatment Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Ophthalmology Treatment Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Ophthalmology Treatment Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Ophthalmology Treatment Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Ophthalmology Treatment Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Ophthalmology Treatment Revenue, (US$, Mn), 2022-2027
Table 30. Allergan Corporate Summary
Table 31. Allergan Ophthalmology Treatment Product Offerings
Table 32. Allergan Ophthalmology Treatment Revenue (US$, Mn), (2016-2021)
Table 33. Aerie Pharmaceuticals Corporate Summary
Table 34. Aerie Pharmaceuticals Ophthalmology Treatment Product Offerings
Table 35. Aerie Pharmaceuticals Ophthalmology Treatment Revenue (US$, Mn), (2016-2021)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Ophthalmology Treatment Product Offerings
Table 38. Pfizer Ophthalmology Treatment Revenue (US$, Mn), (2016-2021)
Table 39. Valeant Corporate Summary
Table 40. Valeant Ophthalmology Treatment Product Offerings
Table 41. Valeant Ophthalmology Treatment Revenue (US$, Mn), (2016-2021)
Table 42. Bayer Corporate Summary
Table 43. Bayer Ophthalmology Treatment Product Offerings
Table 44. Bayer Ophthalmology Treatment Revenue (US$, Mn), (2016-2021)
Table 45. Genentech Corporate Summary
Table 46. Genentech Ophthalmology Treatment Product Offerings
Table 47. Genentech Ophthalmology Treatment Revenue (US$, Mn), (2016-2021)
Table 48. Novartis Corporate Summary
Table 49. Novartis Ophthalmology Treatment Product Offerings
Table 50. Novartis Ophthalmology Treatment Revenue (US$, Mn), (2016-2021)
Table 51. Regeneron Corporate Summary
Table 52. Regeneron Ophthalmology Treatment Product Offerings
Table 53. Regeneron Ophthalmology Treatment Revenue (US$, Mn), (2016-2021)
Table 54. Takeda Corporate Summary
Table 55. Takeda Ophthalmology Treatment Product Offerings
Table 56. Takeda Ophthalmology Treatment Revenue (US$, Mn), (2016-2021)
Table 57. Santen Pharmaceutical Corporate Summary
Table 58. Santen Pharmaceutical Ophthalmology Treatment Product Offerings
Table 59. Santen Pharmaceutical Ophthalmology Treatment Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Ophthalmology Treatment Segment by Type
Figure 2. Ophthalmology Treatment Segment by Application
Figure 3. Global Ophthalmology Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Ophthalmology Treatment Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Ophthalmology Treatment Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Ophthalmology Treatment Revenue in 2020
Figure 8. By Type - Global Ophthalmology Treatment Revenue Market Share, 2016-2027
Figure 9. By Application - Global Ophthalmology Treatment Revenue Market Share, 2016-2027
Figure 10. By Region - Global Ophthalmology Treatment Revenue Market Share, 2016-2027
Figure 11. By Country - North America Ophthalmology Treatment Revenue Market Share, 2016-2027
Figure 12. US Ophthalmology Treatment Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Ophthalmology Treatment Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Ophthalmology Treatment Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Ophthalmology Treatment Revenue Market Share, 2016-2027
Figure 16. Germany Ophthalmology Treatment Revenue, (US$, Mn), 2016-2027
Figure 17. France Ophthalmology Treatment Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Ophthalmology Treatment Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Ophthalmology Treatment Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Ophthalmology Treatment Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Ophthalmology Treatment Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Ophthalmology Treatment Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Ophthalmology Treatment Revenue Market Share, 2016-2027
Figure 24. China Ophthalmology Treatment Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Ophthalmology Treatment Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Ophthalmology Treatment Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Ophthalmology Treatment Revenue, (US$, Mn), 2016-2027
Figure 28. India Ophthalmology Treatment Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Ophthalmology Treatment Revenue Market Share, 2016-2027
Figure 30. Brazil Ophthalmology Treatment Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Ophthalmology Treatment Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Ophthalmology Treatment Revenue Market Share, 2016-2027
Figure 33. Turkey Ophthalmology Treatment Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Ophthalmology Treatment Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Ophthalmology Treatment Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Ophthalmology Treatment Revenue, (US$, Mn), 2016-2027
Figure 37. Allergan Ophthalmology Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Aerie Pharmaceuticals Ophthalmology Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Pfizer Ophthalmology Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Valeant Ophthalmology Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Bayer Ophthalmology Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Genentech Ophthalmology Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Novartis Ophthalmology Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Regeneron Ophthalmology Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Takeda Ophthalmology Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Santen Pharmaceutical Ophthalmology Treatment Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Allergan
Aerie Pharmaceuticals
Pfizer
Valeant
Bayer
Genentech
Novartis
Regeneron
Takeda
Santen Pharmaceutical